NASDAQ Hearings Panel Grants Speedus Maximum Extension to Regain Compliance with Listing Requirements

Thursday, April 15, 2010 General News J E 4

FREEHOLD, N.J., April 15 /PRNewswire-FirstCall/ -- Speedus Corp. (Nasdaq: SPDE), today announced that on April 12, 2010 it received notice that the NASDAQ Hearings Panel (the "Panel") granted the Company the maximum allowable extension to regain compliance with Listing Rule 5550(b) (the “Rule”), which requires stockholders’ equity of at least $2.5 million. The Panel's decision follows the hearing that took place on March 11, 2010, at which time Speedus' management presented the Panel with a plan for regaining and sustaining compliance with the Rule.

About Speedus Corp.

Speedus Corp. (NASDAQ: SPDE) operates through its two majority subsidiaries, Zargis Medical Corp. and Density Dynamics, Inc. Additional information on Speedus Corp. may be obtained at or by contacting Peter Hodge at 888-773-3669 (ext. 23) or

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

SOURCE Speedus Corp.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Dendreon Appoints Richard Ranieri as Senior Vice P...
IPC The Hospitalist Company, Inc. to Report First ...